| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 03/01/2007 | US20070049573 Pyrrole-Derivatives as Factor Xa Inhibitors |
| 03/01/2007 | US20070049570 Quinoline derivatives as phosphodiesterase inhibitors |
| 03/01/2007 | US20070049566 Methods and Compositions for inhibition of angiogenesis |
| 03/01/2007 | US20070049558 New Spirotricyclic Derivatives and Their Use as Phosphodiesterase-7 Inhibitors |
| 03/01/2007 | US20070049536 3-Azabicyclo[3.1.0]hexane-amide derivatives; human T-cell leukemia/lymphoma and lymphadenopathy associated virus, AIDS, cytomegalovirus (CMV) and Epstein-Barr virus (EBV), liver disease such as alcoholism and primary biliar cirrhosis |
| 03/01/2007 | US20070049495 1-Methyl, 3-trifluoromethyl,4-(2-(4-(tert-butylpyrazol-1-yl),2-cyano,1-tert-butylcarbonyloxy)ethylene)-pyrazole; agriculture; preventing the attachment of aquatic organisms to boats, construction materials, heat excangers; coolants; water supply systems; engineering plants; reservoirs; marine/underwater |
| 03/01/2007 | US20070048286 Method of treating dopaminergic and GABA-nergic disorders |
| 03/01/2007 | CA2621164A1 Derivative having ppar agonistic activity |
| 03/01/2007 | CA2620835A1 Delta and epsilon crystal forms of imatinib mesylate |
| 03/01/2007 | CA2620414A1 Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase |
| 03/01/2007 | CA2620171A1 Imidazole derivatives as functionally selective alpha2c adrenoreceptor agonists |
| 03/01/2007 | CA2620052A1 Indenoisoquinolinone analogs and methods of use thereof |
| 03/01/2007 | CA2619770A1 Phenylpyridone derivative |
| 03/01/2007 | CA2619365A1 Pyrazolopyridine and pyrazolopyrimidine compounds useful as kinase enzymes modulators |
| 03/01/2007 | CA2619101A1 Immunosuppressant compounds and compositions |
| 03/01/2007 | CA2619037A1 Bicyclic heterocycles medicaments comprising said compounds use and method for production thereof |
| 03/01/2007 | CA2618479A1 Pyrazine derivatives and use as pi3k inhibitors |
| 03/01/2007 | CA2617519A1 Agent for treating atrial fibrillation |
| 03/01/2007 | CA2616801A1 Novel processes for the production of amorphous rabeprazole sodium |
| 02/28/2007 | EP1757601A1 Quinoline derivatives and their use in glaucoma and myopia |
| 02/28/2007 | EP1757600A2 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 02/28/2007 | EP1757599A1 Indole derivatives having piperidine rings |
| 02/28/2007 | EP1757598A1 Substituted pyrrolidine derivative |
| 02/28/2007 | EP1757594A1 Quinazoline derivative |
| 02/28/2007 | EP1757592A1 Novel 3-phenyltetrahydrocinnolin-5-ol derivative and medicinal use thereof |
| 02/28/2007 | EP1757591A1 Cinnamide compound |
| 02/28/2007 | EP1757584A1 Heterocyclic substituted amides, their production and their use |
| 02/28/2007 | EP1757582A1 Arylalkylamines and process for production thereof |
| 02/28/2007 | EP1756109A1 Novel indole derivatives as selective androgen receptor modulators (sarms) |
| 02/28/2007 | EP1756106A1 Cyclohexylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 02/28/2007 | EP1756096A1 Indolyl derivatives as liver-x-receptor modulators |
| 02/28/2007 | EP1756094A1 3-cycloalkylbenzazepines as histamine h3 antagonists |
| 02/28/2007 | EP1756091A1 Non nucleoside reverse transcriptase inhibitors |
| 02/28/2007 | EP1756090A1 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 02/28/2007 | EP1756089A1 Mercaptoimidazoles as ccr2 receptor antagonists |
| 02/28/2007 | EP1756088A1 Quinazoline derivatives as erbb receptor tyrosine kinases |
| 02/28/2007 | EP1756087A1 Amino-5,5-diphenylimidazolone derivatives for the inhibition of beta-secretase |
| 02/28/2007 | EP1756086A1 Pyridin-4-yl-ethynyl-imidazoles and pyrazoles as mglu5 receptor antagonists |
| 02/28/2007 | EP1756085A1 Diastereoselective synthesis process with 6-bromo-4-(3-chlorophenyl)-2-methoxy-quinoline |
| 02/28/2007 | EP1756084A2 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 02/28/2007 | EP1756083A1 3-arylsulfonyl-quinolines as 5-ht6 receptor antagonists for the treatment of cns disorders |
| 02/28/2007 | EP1756069A2 Hiv integrase inhibitors |
| 02/28/2007 | EP1756065A1 Anti-cytokine heterocyclic compounds |
| 02/28/2007 | EP1756063A1 Amido compounds and their use as pharmaceuticals |
| 02/28/2007 | EP1756060A1 Therapeutic compounds: pyridine as scaffold |
| 02/28/2007 | EP1756054A1 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitor |
| 02/28/2007 | EP1756051A1 Histamine h3 receptor agents, preparation and therapeutic uses |
| 02/28/2007 | EP1755613A2 Substituted cyclic urea derivatives |
| 02/28/2007 | EP1755606A1 Quinazolinone derivatives useful as vanilloid antagonists |
| 02/28/2007 | EP1755593A1 Naphthaline derivatives useful as histamine-3-receptor ligands |
| 02/28/2007 | EP1755396A1 Piperazin derivatives and their use in controlling pests |
| 02/28/2007 | EP1501795B1 Cinnamic acid amides |
| 02/28/2007 | EP1456197B1 Piperidine-2,6-diones that are heterocyclically substituted in position 3 |
| 02/28/2007 | EP1441734B1 Dihydroxypyrimidine carboxamide inhibitors of hiv integrase |
| 02/28/2007 | EP1415987B1 Nitrogenous aromatic ring compounds as anti cancer agents |
| 02/28/2007 | EP1397350B1 Isoquinolinone derivatives as parp inhibitors |
| 02/28/2007 | EP1379505B1 Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas |
| 02/28/2007 | EP1370531B1 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors |
| 02/28/2007 | EP1343561B1 Serine protease inhibitors |
| 02/28/2007 | EP1265606B9 Cell adhesion inhibitors |
| 02/28/2007 | EP1240154B1 Serine protease inhibitors |
| 02/28/2007 | EP1102753B1 Pyrazoles as estrogen receptor modulators |
| 02/28/2007 | CN1922193A Chemical process |
| 02/28/2007 | CN1922177A Aryl- and heteroaryl-piperidinecarboxylate derivatives, the preparation and the use thereof in the form of FAAH enzyme inhibitors |
| 02/28/2007 | CN1922174A 病毒聚合酶抑制剂 Viral polymerase inhibitor |
| 02/28/2007 | CN1922171A Pyrimidine derivative |
| 02/28/2007 | CN1922170A Novel hydroxy-6-heroarylphenanthridines and their use as pde4 inhibitors |
| 02/28/2007 | CN1922169A Spirocyclic heterocyclic derivatives and methods of their use |
| 02/28/2007 | CN1922151A Substituted azole derivatives, compositions, and methods of use |
| 02/28/2007 | CN1922148A Pyrazole derivatives as protein kinase modulators |
| 02/28/2007 | CN1922147A Novel style heterocyclic compound as insulin-like growth factors first type acceptor inhibitor |
| 02/28/2007 | CN1922146A Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors |
| 02/28/2007 | CN1922144A Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs |
| 02/28/2007 | CN1922141A Novel heterocyclic compound |
| 02/28/2007 | CN1922139A Bicyclic amide derivatives |
| 02/28/2007 | CN1922138A Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics |
| 02/28/2007 | CN1921863A 免疫抑制剂化合物和组合物 Immunosuppressant compounds and compositions |
| 02/28/2007 | CN1919844A Method for aqueous phase oxo-synthesis of Iansoprazole |
| 02/28/2007 | CN1302060C Novel flame retarding compounds |
| 02/28/2007 | CN1302002C Hydroxylamine esters as polymerization initiators |
| 02/28/2007 | CN1301991C Piperidine derivatives, process for preparation thereof, and pharmaceutical composition for alzheimer's disease containing the same |
| 02/28/2007 | CN1301990C Environmental protection reactive dyeing and use thereof |
| 02/28/2007 | CN1301975C 1,2-diaryl benzimidazole derivative for treating illnesses associated with microglia activation |
| 02/28/2007 | CN1301973C Heterocyclic derivatives and medicines |
| 02/28/2007 | CN1301972C Piperidine compounds as muscarinic antagonists |
| 02/28/2007 | CN1301970C 2,4-substituted indoles and their use as 5-HT6 modulators |
| 02/28/2007 | CN1301969C New mandelic acid derivatives and their use as thrombin inhibitors |
| 02/28/2007 | CN1301963C Process for producing N-(4-fluobenzene radical)-N-(2-hydroxy-4-chlorobenzene group) glycocoll |
| 02/28/2007 | CN1301712C Indolyl-3-glyoxylic acid derivatives comprising therapeutically valuable properties |
| 02/27/2007 | US7183447 Preparation of ring compounds via a combinatorial synthesis based on a Suzuki coupling, subsequent halo-demetallation and finally a Suzuki coupling; Suzuki couplings are each carried out with a boronic acid or a boronic acid ester |
| 02/27/2007 | US7183415 Melanin-concentrating hormone antagonistic action for treating obesity, for example 4'-fluoro-N-[8-methyl-3-(1-pyrrolidinylmethyl)-7-quinolinyl][1,1'-biphenyl]-4-carboxamide |
| 02/27/2007 | US7183414 Processes for the preparation of benzoimidazole derivatives |
| 02/27/2007 | US7183413 Aminoquinoline compounds |
| 02/27/2007 | US7183412 Ester or amide derivatives |
| 02/27/2007 | US7183411 Naphthol, quinoline and isoquinoline-derived urea modulators of vanilloid VR1 receptor |
| 02/27/2007 | US7183408 calcium atorvastatin (Lipitor) intermediate; from claimed intermediate 5-(4-fluorophenyl)-2-isopropyl-1-(3-morpholin-4-yl-3-oxo-propyl)-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide; via diol esters from the 1,3,5-tricarbonyl precursors in a stereoselective ruthenium-catalyzed hydrogenation |
| 02/27/2007 | US7183318 Substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/27/2007 | US7183306 Pyrazole derivatives |
| 02/27/2007 | US7183305 Reaction of cyano compound with silylalkylisocyanide for active imidazoles |
| 02/27/2007 | US7183304 Heterocyclic compounds and methods of use |